论文信息 - The Combination of Insulin-Like Growth Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane as a First-Line Therapy for Patients with Recurrent/Metastatic Adrenocortical Carcinoma: a Multi-institutional NCI-Sponsored Trial - 字舞流文

The Combination of Insulin-Like Growth Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane as a First-Line Therapy for Patients with Recurrent/Metastatic Adrenocortical Carcinoma: a Multi-institutional NCI-Sponsored Trial

G. Hammer | Krishna Rao | W. Stadler | F. Worden | M. Shah | A. Lerário | T. Else | E. Agamah | Carole A. Ramm | Elizabeth A. Hasseltine | M. Shah